Literature DB >> 13852511

The effects of triparanol (MER-29) in subjects with and without coronary artery disease.

W HOLLANDER, A V CHOBANIAN, R W WILKINS.   

Abstract

Entities:  

Keywords:  CHOLESTEROL/antagonists; CHOLESTEROL/blood; CORONARY DISEASE/blood

Mesh:

Substances:

Year:  1960        PMID: 13852511     DOI: 10.1001/jama.1960.03030010007002

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  4 in total

1.  The metabolism of desmosterol in human subjects during triparanol administration.

Authors:  D S GOODMAN; J AVIGAN; H WILSON
Journal:  J Clin Invest       Date:  1962-05       Impact factor: 14.808

2.  EFFECTS OF TRIPARANOL (MER-29) ON CHOLESTEROL BIOSYNTHESIS AND ON BLOOD STEROL LEVELS IN MAN.

Authors:  D Steinberg; J Avigan; E B Feigelson
Journal:  J Clin Invest       Date:  1961-05       Impact factor: 14.808

3.  MER-29 (triparanol) in the control of hypercholesterolaemia.

Authors:  E M JEPSON
Journal:  Proc R Soc Med       Date:  1962-06

Review 4.  50th anniversary of the first clinical trial with ICI 46,474 (tamoxifen): then what happened?

Authors:  V Craig Jordan
Journal:  Endocr Relat Cancer       Date:  2021-01       Impact factor: 5.678

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.